Screening questions can signal a legitimate paid study when they are clearly tied to eligibility, explain what information is being collected, and lead to transparent details about the sponsor, procedures, payment, privacy, and consent. No single question proves an offer is real, however. For example, a university sleep study may reasonably ask about age, diagnosed sleep conditions, medications, and overnight availability before discussing enrollment, but the opportunity should still be verified through the university or named research center. A credible recruiter should also answer your questions. You should be able to learn the exact compensation, reimbursement policy, study location, time commitment, eligibility rules, data use, and responsible contact before participating.
For a clinical study, ask for its NCT number and compare the invitation with the corresponding ClinicalTrials.gov record. A listing is useful corroboration, not an FDA endorsement or a guarantee that every detail remains current. Paid focus groups, product interviews, survey panels, and clinical studies do not all use the same screening process. A market researcher may ask which brands you buy, while a clinical team may need relevant medical history. In either setting, specific and proportionate questions are more credible than an unexplained request for a Social Security number, bank login, credit-card number, or participation fee.
Table of Contents
- Which Screening Questions Signal a Legit Paid Study Opportunity?
- Payment, Reimbursement, and Timing Questions
- How to Verify the Sponsor, Study Site, and NCT Number
- Questions to Ask Before Sharing Personal Information
- Consent, Risks, Privacy, and the Right to Withdraw
- Eligibility Questions Versus Premature Acceptance
- A Practical Verification Test for Focus Groups and Survey Panels
Which Screening Questions Signal a Legit Paid Study Opportunity?
legitimate screening questions usually test a stated eligibility requirement. Common subjects include age range, location, occupation, purchasing habits, technology use, scheduling availability, and prior participation in similar research. Clinical-study screens may also ask about the type or stage of an illness, treatment history, medications, or other medical conditions. According to the National Institute of Mental Health, study-specific inclusion and exclusion criteria help protect participants and improve the accuracy of research data. Context matters as much as the question itself.
Suppose a research company is organizing a 90-minute discussion with people who recently purchased an electric bicycle. Questions about when you bought the bicycle, where you purchased it, and which models you considered fit the research purpose. Questions about an unrelated medical diagnosis or your online-banking credentials would not. A real screening process may reject applicants. Focus groups often need a particular mix of customers, noncustomers, age groups, or professional roles; a clinical study may exclude someone because of a medication interaction or medical condition. Instant acceptance regardless of how you answer can be a warning, especially when the supposed recruiter quickly pivots to collecting financial information.
Payment, Reimbursement, and Timing Questions
Ask, “What is the exact payment amount, which expenses are reimbursed, and when is each payment made?” compensation should be explained plainly rather than left as “up to” an impressive amount with no breakdown. For a multivisit study, request the amount attached to each visit, whether travel or parking is reimbursed separately, and what happens if the research team ends your participation early. The FDA's guidance on payments to research subjects says payment for participation is generally acceptable and is reviewed by an institutional review board, or IRB, for issues including timing and undue influence. Payment is a recruitment incentive or compensation for time and inconvenience; it is not a medical benefit.
Payment details should appear in the informed-consent document, and credit generally should accrue as participation progresses instead of being wholly contingent on completing every study activity. Advertising can mention that participants will be paid, but the FDA's recruiting guidance advises clinical-research advertisements against emphasizing the payment or its amount. An ad centered on the investigator, facility, research purpose, condition, and basic eligibility criteria is more informative than one dominated by a large dollar figure. Even then, compensation alone neither establishes legitimacy nor shows that participating is medically appropriate.
How to Verify the Sponsor, Study Site, and NCT Number
For a clinical study, ask, “What is the NCT number, sponsor, study site, and responsible-party contact?” An NCT number identifies a record on ClinicalTrials.gov. The record may show recruitment status, eligibility criteria, study locations, contacts, sponsor, responsible party, and the date the record was last updated, as described in ClinicalTrials.gov's guide to reading study records. Compare the record with the invitation rather than merely confirming that a number exists. If a text message claims to recruit for a Boston hospital, but the cited record lists only sites in California and Texas, contact the sponsor or hospital using independently obtained information.
Do not rely on the phone number, link, or email signature in the unsolicited message to perform that verification. ClinicalTrials.gov cautions that it does not take responsibility for submitted record information or for the research itself, and records can become outdated. Its study-participation guidance therefore supports using the registry as a starting point, not a seal of approval. “Recruiting,” a positive trial result, an investigational new drug filing, an emergency use authorization, and full FDA approval are separate statuses; a recruiter should not blur them together.
Questions to Ask Before Sharing Personal Information
Ask what the phone or online screen will collect, why each category is needed, who will receive it, and how long it will be retained. Basic questions about contact information, age, demographics, and relevant health conditions can be appropriate. A survey panel may need an email address to send invitations, while a clinical site may need a phone number to arrange a formal eligibility interview. The tradeoff is that researchers need enough information to identify suitable participants, but applicants should not have to surrender high-risk financial or identity data merely to be considered.
The Federal Trade Commission specifically warns that purported clinical trials should not request a Social Security number during recruitment or screening. It also warns against providing bank-account, routing, or credit-card details at that stage. Never pay an application fee, enrollment charge, membership upgrade, or “refundable deposit” to participate in or learn about a study. The FTC states that real clinical trials do not charge people to join or to obtain information about a trial. A request to purchase gift cards, send cryptocurrency, deposit a check and return part of the proceeds, or pay for a background check through the recruiter’s link is not a normal research-screening step.
Consent, Risks, Privacy, and the Right to Withdraw
For clinical research, ask what the consent form says about procedures, foreseeable risks, possible benefits, alternatives, privacy, costs, injury care, contacts, payment timing, and withdrawal. The HHS Office for Human Research Protections recommends that volunteers ask who sponsors the study, who reviewed and approved it, whether an intervention is experimental, how information will be protected, and what happens if a research-related injury occurs. Consent is a process, not just a signature page. A credible team should give you time to read the document and ask questions.
Pressure to sign immediately, instructions to leave sections blank, or claims that the form is unavailable until after a procedure are serious warnings. For nonclinical research, look for a comparable privacy notice or participation agreement explaining recording, data use, confidentiality, incentives, and the researcher’s contact information. Participation must be voluntary. FDA informed-consent requirements say people must be told that refusing to participate carries no penalty or loss of benefits to which they are otherwise entitled, and that they may discontinue at any time without such a penalty or loss. Compensation already earned should be handled according to the disclosed payment schedule; a promise to forfeit everything unless every activity is completed deserves careful scrutiny.
Eligibility Questions Versus Premature Acceptance
Ask, “Am I eligible now, or only after a study-team screen?” Completing an online questionnaire rarely means final enrollment in clinical research. A coordinator may need to review records, conduct an interview, perform laboratory testing, or confirm that medications and medical conditions fit the protocol.
For example, an advertisement may seek adults ages 40 to 65 with a particular diagnosis. Meeting those two visible criteria may unlock a phone screen, but treatment history or another condition could still make the person ineligible. A recruiter who guarantees acceptance before checking protocol-specific criteria is making a promise the formal study team may not be able to keep.
A Practical Verification Test for Focus Groups and Survey Panels
For a paid focus group or survey panel, ask for the legal business name, research purpose, session format, duration, recording policy, incentive amount, payment method, and payment date. Then verify the organization through a website or contact channel you found independently. A company-domain email and clear project details are useful signals, although neither is conclusive because domains and identities can be imitated.
Consider two invitations for a remote software interview. One asks about job role, company size, software used, purchasing involvement, and availability, then provides a written privacy notice and a fixed payment schedule. The other promises unusually high pay, accepts every answer, and requests a routing number before scheduling. The first follows a recognizable eligibility process; the second combines indiscriminate acceptance with unnecessary financial-data collection.
